MGMT and glioblastoma: The DNA repair protein, O6 methylguanine-DNA methyltransferase (MGMT), directly inhibits the cytotoxic effect of temozolomide [76,77], and therefore patients with glioblastoma containing MGMT promoter methylation display better overall survival than those with functional and higher expression of MGMT [78,79,80,81].